Similar to RB1, genes that scored as hits both in the Drosophila eye screen and cancer cell line screens had least hazard than any other group of genes in patients with low expression levels of CDKN2A (p16Ink4a) in tumor samples (S10 Fig). This evidence concerns the gene CDKN2A and cancer.